Page last updated: 2024-09-04

ezetimibe and Hypertriglyceridemia

ezetimibe has been researched along with Hypertriglyceridemia in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (18.18)	29.6817
2010's	6 (54.55)	24.3611
2020's	3 (27.27)	2.80

Authors

Authors	Studies
Albers, S; Boch, T; Michaeli, DT; Michaeli, JC; Michaeli, T	1
Di Costanzo, A; Esposito, G; Indolfi, C; Sorrentino, S; Spaccarotella, CAM	1
Casula, M; Catapano, AL; Pirillo, A; Tokgözoğlu, L	1
Abe, M; Fukuda, N; Haketa, A; Hatanaka, Y; Kobayashi, H; Nakamura, Y; Soma, M; Tanaka, S; Tsunemi, A; Ueno, T	1
Hegele, RA; Tsimikas, S	1
Browne, RW; Griffin, JD; Harding, SV; Jones, PJ; Ramprasath, V; Rideout, TC	1
Castaldo, RS	1
Inagaki, M; Ishigami, M; Kawase, R; Komuro, I; Masuda, D; Matsuyama, A; Nakagawa-Toyama, Y; Nakaoka, H; Nakatani, K; Nishida, M; Ohama, T; Sandoval, JC; Tochino, Y; Tsubakio-Yamamoto, K; Yamashita, S; Yuasa-Kawase, M	1
Enko, K; Hata, Y; Ito, H; Kohno, K; Kubo, M; Kusano, KF; Miyoshi, T; Morita, H; Murakami, M; Nakamura, K; Yunoki, K	1
Cottrell, DA; Falko, JM; Marshall, BJ	1
Austin, TM; Cook, JA; Davis, HR; Farley, C; Tetzloff, GG; van Heek, M	1

Reviews

3 review(s) available for ezetimibe and Hypertriglyceridemia

Article	Year
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2023, Volume: 23, Issue:5 Topics: Angiopoietin-Like Protein 3; Anticholesteremic Agents; Cardiovascular Diseases; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Pharmaceutical Preparations; Proprotein Convertase 9; Secondary Prevention	2023
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function. International journal of molecular sciences, 2023, Jul-21, Volume: 24, Issue:14 Topics: Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Eicosapentaenoic Acid; Ezetimibe; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; PCSK9 Inhibitors; Proprotein Convertase 9; Triglycerides	2023
Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome. Current opinion in cardiology, 2003, Volume: 18, Issue:4 Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Ezetimibe; Fenofibrate; Fish Oils; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome; Niacin; Particle Size	2003

Trials

1 trial(s) available for ezetimibe and Hypertriglyceridemia

Article	Year
Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease. The American journal of cardiology, 2011, Aug-01, Volume: 108, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Azetidines; Cholesterol, HDL; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Japan; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Regression Analysis; Secondary Prevention; Triglycerides; Vasodilation	2011

Article

Year

Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease.

The American journal of cardiology, 2011, Aug-01, Volume: 108, Issue:3

Topics: Aged; Angioplasty, Balloon, Coronary; Azetidines; Cholesterol, HDL; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Japan; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Regression Analysis; Secondary Prevention; Triglycerides; Vasodilation

2011

Other Studies

7 other study(ies) available for ezetimibe and Hypertriglyceridemia

Article	Year
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk. Atherosclerosis. Supplements, 2020, Volume: 42 Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus; Europe; Ezetimibe; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; PCSK9 Inhibitors; Practice Guidelines as Topic; Primary Prevention; Renal Insufficiency, Chronic; United States	2020
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia. Internal medicine (Tokyo, Japan), 2019, Jan-15, Volume: 58, Issue:2 Topics: Adult; Age of Onset; Bezafibrate; Diabetes Complications; Ezetimibe; Genetic Variation; Heterozygote; Humans; Hyperlipoproteinemia Type I; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Lipoprotein Lipase; Male	2019
Lipid-Lowering Agents. Circulation research, 2019, Volume: 124, Issue:3 Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Benzimidazoles; Caproates; Cholesterol, HDL; Cholesterol, LDL; Diacylglycerol O-Acyltransferase; Dicarboxylic Acids; Dyslipidemias; Ezetimibe; Fatty Acids; Genetic Therapy; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoprotein(a); Oligonucleotides; RNA, Small Interfering	2019
Phytosterols protect against diet-induced hypertriglyceridemia in Syrian golden hamsters. Lipids in health and disease, 2014, Jan-06, Volume: 13 Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cricetinae; Diet, High-Fat; Drug Evaluation, Preclinical; Ezetimibe; Fatty Acids; Gene Expression; Hypertriglyceridemia; Intestinal Absorption; Intestine, Small; Lipogenesis; Liver; Male; Mesocricetus; Phytosterols; RNA, Messenger; Sterol Regulatory Element Binding Protein 1	2014
A retrospective case series of the lipid effects of switching from omega-3 fatty acid ethyl esters to icosapent ethyl in hyperlipidemic patients. Postgraduate medicine, 2014, Volume: 126, Issue:3 Topics: Aged; Azetidines; Eicosapentaenoic Acid; Esters; Ezetimibe; Fatty Acids, Omega-3; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; New York; Random Allocation; Retrospective Studies	2014
Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia. Journal of atherosclerosis and thrombosis, 2010, Sep-30, Volume: 17, Issue:9 Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-48; Azetidines; Base Sequence; CD36 Antigens; Chylomicrons; Disease Models, Animal; DNA Primers; Ezetimibe; Fatty Acid Transport Proteins; Fatty Acid-Binding Proteins; Hypertriglyceridemia; Intestinal Absorption; Lipoproteins, VLDL; Lymph; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Postprandial Period; RNA, Messenger; Triglycerides; Triolein	2010
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters. Diabetes, 2001, Volume: 50, Issue:6 Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Ezetimibe; Hypercholesterolemia; Hyperinsulinism; Hyperlipidemias; Hypertriglyceridemia; Liver; Mesocricetus; Obesity; Triglycerides	2001